The Role of α-Synuclein and LRRK2 in Tau Phosphorylation

Joint Authors

Takeda, Yuko
Ichikawa, Takafumi

Source

Parkinson’s Disease

Issue

Vol. 2015, Issue 2015 (31 Dec. 2015), pp.1-10, 10 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2015-04-21

Country of Publication

Egypt

No. of Pages

10

Main Subjects

Diseases
Medicine

Abstract EN

There is now a considerable body of experimental evidence that Parkinson’s disease arises through physiological interaction of causative molecules, leading to tau pathology.

In this review, we discuss the physiological role of α-synuclein and LRRK2 in the abnormal phosphorylation of tau.

In addition, as recent reports have indicated that heat shock proteins- (HSPs-) inducing drugs can help to ameliorate neurodegenerative diseases associated with tau pathology, we also discuss therapeutic strategies for PD focusing on inhibition of α-synuclein- and LRRK2-associated tau phosphorylation by HSPs.

American Psychological Association (APA)

Takeda, Yuko& Ichikawa, Takafumi. 2015. The Role of α-Synuclein and LRRK2 in Tau Phosphorylation. Parkinson’s Disease،Vol. 2015, no. 2015, pp.1-10.
https://search.emarefa.net/detail/BIM-1075909

Modern Language Association (MLA)

Takeda, Yuko& Ichikawa, Takafumi. The Role of α-Synuclein and LRRK2 in Tau Phosphorylation. Parkinson’s Disease No. 2015 (2015), pp.1-10.
https://search.emarefa.net/detail/BIM-1075909

American Medical Association (AMA)

Takeda, Yuko& Ichikawa, Takafumi. The Role of α-Synuclein and LRRK2 in Tau Phosphorylation. Parkinson’s Disease. 2015. Vol. 2015, no. 2015, pp.1-10.
https://search.emarefa.net/detail/BIM-1075909

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1075909